BioMarin Expands PKU Dominion With EU Approval Of Palynziq
Executive Summary
Palynziq has received European Commission approval to treat phenylketonuria a year after the US FDA gave it the green light. BioMarin now markets the only two approved treatments for the condition.
You may also be interested in...
Titans Of Pharma 2020: 15 Leading CEOs Bag $266m In Compensation
See how much the CEOs and R&D heads of the world’s biggest pharma companies get paid, and how those companies are performing.
ASCO: Keytruda Inches Uncertainly Towards Tecentriq In Triple-Negative Breast Cancer
Merck & Co is gradually catching up with Roche in PD-1/L1 first-line triple-negative breast cancer treatment, but its presentation at ASCO on Keynote-355 includes mixed PFS results. Overall survival data will be key to Keytruda’s competitiveness.
Titans Of Pharma 2020: A Bumper Year For Top Executive Compensation
INFOGRAPHIC: A snapshot of the compensation packages granted to the chiefs of the world’s biggest pharma companies, along with key performance stats for the businesses they lead.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports